Trial intelligence / Profile preview

Pilot randomized trial of atazanavir/ritonavir versus nevirapine on lipid profile in antiretroviral-naive HIV patients

2007-007882-19Phase 3Terminated

Sponsor
ASST Spedali Civili di Brescia
Start
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS) comparing atazanavir + ritonavir regimen with nevirapine regimen (2 arms). Primary endpoints: hypercholesterolemia (HDL/LDL) and hypertriglyceridemia. Started Dec 2007; status: terminated.

02

Drugs

atazanavirnevirapine
03

Conditions

human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)

Beyond the preview

Go deeper on 2007-007882-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007882-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call